Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease

Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease

<p>Abstract</p> <p>Background</p> <p>Genetically engineered neural stem cell (NSC) lines are promising vectors for the treatment of neurodegenerative diseases, particularly Parkinson's disease (PD). Neurturin (NTN), a member of the glial cell line-derived neurotrop...

Full description

Bibliographic Details
Main Authors:	Wang Gang, Li Biao, Lu Guo-Qiang, Wang Xi-Jing, Liu Wei-Guo, Chen Sheng-Di
Format:	Article
Language:	English
Published:	BMC 2007-10-01
Series:	Molecular Neurodegeneration
Online Access:	http://www.molecularneurodegeneration.com/content/2/1/19

Similar Items

Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
by: Wang Gang, et al.
Published: (2009-11-01)

Intraputamenal Infusion of Exogenous Neurturin Protein Restores Motor and Dopaminergic Function in the Globus Pallidus of MPTP-Lesioned Rhesus Monkeys
by: R. Grondin Ph.D., et al.
Published: (2008-04-01)

Sputum Neurturin Levels in Adult Asthmatic Subjects
by: Sato S, et al.
Published: (2023-08-01)

Créditos 17.2
by: Créditos 17.2
Published: (2012-11-01)

Whole issue 17.2
by: Language Value
Published: (2024-12-01)

Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat
by: Klein Robert D, et al.
Published: (2007-03-01)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
by: Shane V Hegarty, et al.
Published: (2017-01-01)

Reseñas / Reviews núm. 17.2
by: Montserrat Antonín Martín, et al.
Published: (2018-05-01)

Neurturin Evokes MAPK-Dependent Upregulation of Egr4 and KCC2 in Developing Neurons
by: Anastasia Ludwig, et al.
Published: (2011-01-01)

Effects of IGFBP-2 on proliferation and differentiation in neural stem cell line C17.2
by: Deng Y, et al.
Published: (2017-07-01)

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
by: Min Yan, et al.
Published: (2013-01-01)

Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway
by: Lei Liu, et al.
Published: (2015-07-01)

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
by: Zhang Shi, et al.
Published: (2011-11-01)

Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01)

Neurturin Gene Therapy Protects Parasympathetic Function to Prevent Irradiation-Induced Murine Salivary Gland Hypofunction
by: Joao N.A. Ferreira, et al.
Published: (2018-06-01)

Overexpression of GmWRKY172 enhances cadmium tolerance in plants and reduces cadmium accumulation in soybean seeds
by: Peiqi Xian, et al.
Published: (2023-03-01)

Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease.
by: Yue Wang, et al.
Published: (2013-01-01)

Dopaminergic and non-dopaminergic mechanisms of non-motor symptoms of Parkinson disease
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
by: Beevers, J, et al.
Published: (2013)

Induced pluripotent stem cell–related approaches to generate dopaminergic neurons for Parkinson’s disease
by: Ling-Xiao Yi, et al.
Published: (2025-11-01)

GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway
by: Zongkui Wang, et al.
Published: (2018-09-01)

Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation
by: Jia-Wen Shou, et al.
Published: (2019-09-01)

Dopaminergic Neuroprotection with Ginkgolide in 6-Hydroxydopamine Rat Parkinson’s Disease Model
by: Alireza Moghadam, et al.
Published: (2019-03-01)

Effect of dopaminergic therapy on lacrimation in Parkinson's disease
by: A. A. Pilipovich, et al.
Published: (2023-12-01)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
by: Alberto Costa, et al.
Published: (2008-01-01)

LONG-TERM DOPAMINERGIC THERAPY OF PARKINSON DISEASE
by: O. S. Levin
Published: (2017-05-01)

Dopaminergic modulation of emotional conflict in Parkinson’s disease
by: Vanessa eFleury, et al.
Published: (2014-07-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Visualization of dopaminergic midbrain structures in Parkinson’s disease
by: R. R. Bogdanov, et al.
Published: (2017-02-01)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
by: Yanqin Wang, et al.
Published: (2017-01-01)

Genetic analysis of transcription factors in dopaminergic neuronal development in Parkinson's disease
by: Yuwen Zhao, et al.
Published: (2024-02-01)

Curcumin inhibits oxidative stress and autophagy in C17.2 neural stem cell through ERK1/2 signaling pathways
by: Yuting Ruan, et al.
Published: (2024-10-01)

No synergism between bis(propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson's disease mice
by: Cheng-you Zheng, et al.
Published: (2016-01-01)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
by: MA Qamar, et al.
Published: (2017-01-01)

Parkinson's disease : non-motor and non-dopaminergic features /
by: Olanow, C. W. (Charles Warren), 1941-, et al.
Published: (2011)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
by: Byounggook Cho, et al.
Published: (2024-11-01)

Influence of depressive symptoms on dopaminergic treatment of Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2014-09-01)

Roles of FGF20 in dopaminergic neurons and Parkinson’s disease
by: Nobuyuki eItoh, et al.
Published: (2013-05-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment
by: Jinming Liu, et al.
Published: (2024-10-01)